Mahavir Prashad

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
NOVARTIS AG
1
1
2
1
3
2
1
2
3
4
5
2
1
2
1995
1998
1999
2002
2003
2004
2005
2006
2008
2010
2011
2012
2014
2016
NOVARTIS TIERGESUNDHEIT AG
2
2007
Sandoz Pharmaceuticals Corp.
1
1987
ANORMED INC.
1
1995
Sandoz Ltd.
1
1
1994
1995
NOVARTIS PHARMACEUTICALS CORPORATION
2
2
1
1
1998
2006
2014
2016
BI-PATENT HOLDING S.A.
1
1995

Inventor Addresses

AddressDuration
East Hanover, NJ, USMay 12, 11 - Sep 24, 19
Hopatcong, NJSep 19, 89 - Nov 25, 97
Montville, NJMar 28, 00 - Dec 04, 08
Montville, NJ, USOct 02, 03 - Oct 20, 22

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 28
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 5

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2022/0331,2822022AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS0
114263752022Substituted bisphenyl butanoic ester derivatives as NEP inhibitors0
2022/0257,5512022AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS0
2021/0361,6102021COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONS0
110969182021Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.